Bhaskar Anand Net Worth & Insider Trades
Bhaskar Anand - SVP, Reata Pharmaceuticals Inc
What is Bhaskar Anand's Net Worth?
The current estimated net worth of Reata Pharmaceuticals Inc's SVP, Bhaskar Anand, is estimated to be about $2.19M . Bhaskar Anand owns about 24,089 units of Reata Pharmaceuticals Inc common stock. In the last year at Reata Pharmaceuticals Inc, Bhaskar Anand has sold an estimated value of $554.33K worth.
What is Bhaskar Anand's Past Insider Trading?
Bhaskar Anand's largest purchase order was 1,562 units , worth over $42.67K on June 16, 2023. Bhaskar Anand's largest sale order was 2,343 units , worth over $239.25K on June 16, 2023. In total, Bhaskar Anand has made about 9 transactions over a year of their time at Reata Pharmaceuticals Inc. Bhaskar Anand usually trades in March, with the busiest year in 2023. The most recent transaction was a sale order of 406 units , worth over $68.7K on September 7, 2023.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Bhaskar Anand
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is Bhaskar Anand's' Mailing Address?
- Mailing address is 5320 Legacy Drive Plano TX 75024 TX
Reata Pharmaceuticals Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
Total
|
|---|---|---|---|---|---|---|---|
| J. Warren Huff | 2020 | $636,400 | $413,660 | - | $5,000 | $5,000 | $6,396,130 |
| J. Warren Huff | 2019 | $578,500 | $600,540 | - | $16,715 | $16,715 | $5,542,605 |
| J. Warren Huff | 2018 | $534,000 | $400,500 | - | - | - | $934,500 |
| Manmeet S. Soni | 2020 | $545,900 | $445,700 | - | $136,125 | $136,125 | $4,465,894 |
| Manmeet S. Soni | 2019 | $179,385 | $408,873 | - | $70,243 | $70,243 | $12,261,587 |
| Dawn C. Bir | 2020 | $422,000 | $239,900 | - | $5,000 | $5,000 | $3,871,542 |
| Dawn C. Bir | 2019 | $375,100 | $287,550 | - | $3,500 | $3,500 | $1,975,899 |
| Colin J. Meyer, M.D. | 2020 | $513,951 | $381,400 | - | - | - | $4,233,520 |
| Colin J. Meyer, M.D. | 2019 | $445,600 | $389,467 | - | - | - | $2,182,780 |
| Colin J. Meyer, M.D. | 2018 | $417,000 | $208,500 | - | - | - | $625,500 |
| Michael D. Wortley | 2020 | $421,100 | $339,500 | - | - | - | $3,965,242 |
| Michael D. Wortley | 2019 | $382,800 | $341,400 | - | - | - | $2,033,949 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1358762/000156459021022192/reta-def14a_20210610.htm
What are Reata Pharmaceuticals Inc's Past Insider Trades?
Reata Pharmaceuticals Inc's most recent insider trade came on September 18, 2023 by Andrea Loewen who sold 3,175 units worth $546.18K . In the last 7 years, insiders at Reata Pharmaceuticals Inc have sold an estimated value of $178.68M and bought an estimated value of $141.88M worth of shares. Insider trading is most common in June, with the busiest year in 2023. The most active traders at the company are R. Kent McGaughy Jr., Douglas Jason Wilson, Executive VP Operations, and Elaine Castellanos, VP .
REATA PHARMACEUTICALS INC Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||